Current treatments for corneal neovascularization rely on invasive intravitreal injections, which limit patient compliance and carry significant risks. To address this, researchers developed a ...
Fluctuating vision is the most frequently cited complaint, exceeding classic discomfort symptoms, and may divert patients toward refractive explanations before DED is recognized and treated.
Please provide your email address to receive an email when new articles are posted on . Thyroid eye disease treatments have evolved significantly in recent years. Work is still needed to find durable, ...
As we age, our eyesight inevitably changes, and so we must focus on new ways to maintain it. Older people with diabetes need to take special care of their vision ...
Once relatively rare, dry eye disease (DED) is now considered one of the most common — and annoying — eye conditions. Here’s what you need to know about determining if you have it, identifying the ...
Researchers have successfully used a new robot system to improve treatment for debilitating eye disease. Researchers from King's, with doctors at King's College Hospital NHS Foundation Trust, have ...
Please provide your email address to receive an email when new articles are posted on . Until recently, patients with active thyroid eye disease had limited options for treatment of their condition ...
Medical experts explore recent therapies in the treatment of dry eye disease. This is a video synopsis/summary of a Stakeholder Summit involving: Ryan Haumschild, PharmD, MS, MBA; Jai G. Parekh, MD, ...
Dry eye disease significantly impacts quality of life, with 75% of sufferers finding it bothersome and many reducing daily activities. A substantial 78% of survey participants desire more educational ...
NovaBridge Biosciences NBP shares are up on Monday following the announcement of positive topline results from the Phase 2a study of VIS-101, a treatment for retinal vascular diseases. Trial Data The ...
Dry eye has emerged as an early warning sign of autoimmune disease, appearing roughly three years before many patients receive a formal diagnosis. That gap reframes a common irritation as a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results